Neuberger Berman International Equity Fund Inst (NBIIX)
13.61
-0.03
(-0.22%)
USD |
Mar 04 2025
Returns Chart
Key Stats
Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
---|---|---|---|
-- | -- | -- | -- |
1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
-- | -- | Upgrade | Upgrade |
Basic Info
Investment Strategy | |
The Fund seeks long-term growth of capital by investing primarily in common stocks of foreign companies. To pursue this goal, the Fund invests mainly in foreign companies of any size, including companies in developed and emerging industrialized markets. . |
General | |
Security Type | Mutual Fund |
Broad Asset Class | International Equity |
Broad Category | Equity |
Global Peer Group | Equity Global ex US |
Peer Group | International Multi-Cap Growth |
Global Macro | Equity Global |
US Macro | Developed International Markets Funds |
YCharts Categorization | -- |
YCharts Benchmark | -- |
Prospectus Objective | International Funds |
Fund Owner Firm Name | Neuberger Berman |
Broad Asset Class Benchmark Index | |
^MSACXUSNTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
--
--
Peer Group Low
--
Peer Group High
1 Year
% Rank:
--
--
Peer Group Low
--
Peer Group High
3 Months
% Rank:
--
--
Peer Group Low
--
Peer Group High
3 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
6 Months
% Rank:
--
--
Peer Group Low
--
Peer Group High
5 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
YTD
% Rank:
--
--
Peer Group Low
--
Peer Group High
10 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of March 05, 2025.
Asset Allocation
As of January 31, 2025.
Type | % Net |
---|---|
Cash | 0.44% |
Stock | 99.56% |
Bond | 0.00% |
Convertible | 0.00% |
Preferred | 0.00% |
Other | 0.00% |
Top 10 Holdings
Name | % Weight | Price | % Change |
---|---|---|---|
Siemens AG | 2.02% | 243.64 | 4.28% |
Novo Nordisk AS | 2.02% | 91.10 | 4.00% |
AstraZeneca PLC | 1.95% | 153.16 | 1.32% |
Experian PLC | 1.78% | 47.66 | 1.05% |
London Stock Exchange Group PLC | 1.72% | 150.38 | 1.30% |
Safran SA | 1.56% | 280.65 | -1.25% |
NatWest Group PLC | 1.49% | 6.10 | 1.16% |
Barclays PLC | 1.48% | 3.81 | -2.81% |
ASML Holding NV | 1.46% | 727.67 | 1.44% |
Lvmh Moet Hennessy Louis Vuitton SE | 1.45% | 717.94 | -0.56% |
Fees & Availability
Fees | |
Actual 12B-1 Fee | -- |
Actual Management Fee | 0.79% |
Administration Fee | 1.11M% |
Maximum Front Load | -- |
Maximum Deferred Load | -- |
Maximum Redemption Fee | 0.00% |
General Availability | |
Available for Insurance Product | -- |
Available for RRSP | -- |
Purchase Details | |
Open to New Investors |
|
Minimum Initial Investment | 1.00M None |
Minimum Subsequent Investment | 0.00 None |
Basic Info
Investment Strategy | |
The Fund seeks long-term growth of capital by investing primarily in common stocks of foreign companies. To pursue this goal, the Fund invests mainly in foreign companies of any size, including companies in developed and emerging industrialized markets. . |
General | |
Security Type | Mutual Fund |
Broad Asset Class | International Equity |
Broad Category | Equity |
Global Peer Group | Equity Global ex US |
Peer Group | International Multi-Cap Growth |
Global Macro | Equity Global |
US Macro | Developed International Markets Funds |
YCharts Categorization | -- |
YCharts Benchmark | -- |
Prospectus Objective | International Funds |
Fund Owner Firm Name | Neuberger Berman |
Broad Asset Class Benchmark Index | |
^MSACXUSNTR | 100.0% |
Fundamentals
General | |
Distribution Yield | -- |
Dividend Yield TTM | -- |
30-Day SEC Yield | -- |
7-Day SEC Yield | -- |
Stock | |
Weighted Average PE Ratio | -- |
Weighted Average Price to Sales Ratio | -- |
Weighted Average Price to Book Ratio | -- |
Weighted Median ROE | -- |
Weighted Median ROA | -- |
ROI (TTM) | -- |
Return on Investment (TTM) | -- |
Earning Yield | -- |
LT Debt / Shareholders Equity | -- |
Growth Metrics
EPS Growth (1Y) | 19.84% |
EPS Growth (3Y) | 21.00% |
EPS Growth (5Y) | 12.80% |
Sales Growth (1Y) | 7.94% |
Sales Growth (3Y) | 13.32% |
Sales Growth (5Y) | 9.39% |
Sales per Share Growth (1Y) | 15.72% |
Sales per Share Growth (3Y) | 13.25% |
Operating Cash Flow - Growth Ratge (3Y) | 12.75% |
As of January 31, 2025
Fund Details
Key Dates | |
Inception Date | 6/17/2005 |
Last Annual Report Date | 8/31/2024 |
Last Prospectus Date | 12/18/2024 |
Share Classes | |
NIQAX | A |
NIQCX | C |
NIQEX | Other |
NIQTX | Other |
NIQVX | Inv |
NRIQX | Retirement |
Attributes | |
Index Fund | -- |
Inverse Fund | -- |
Leveraged Fund | -- |
Fund of Funds | No |
Currency Hedged Fund | -- |
Synthetic Replication Fund | No |
Top Portfolio Holders
Name | % Weight |
---|---|
Portfolio A | 5.00% |
Portfolio B | 3.50% |
Portfolio C | 2.25% |
Excel Add-In Codes
Name: =YCI("M:NBIIX", "name") |
Broad Asset Class: =YCI("M:NBIIX", "broad_asset_class") |
Broad Category: =YCI("M:NBIIX", "broad_category_group") |
Prospectus Objective: =YCI("M:NBIIX", "prospectus_objective") |
To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |